メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
西村 豪人
医学部・循環器内科学
h-index
2107
被引用数
5
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2017
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(8)
類似のプロファイル
(10)
フィンガープリント
Hideto Nishimuraが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
50%
Acute Coronary Syndrome
10%
Acute Heart Failure
85%
Acute Kidney Failure
50%
Adverse Outcome
50%
Bleeding
10%
Brain Natriuretic Peptide
50%
Cardiovascular Disease
78%
Cardiovascular Risk
50%
Cause of Death
35%
Chronic Kidney Failure
10%
Cohort Study
7%
Coronary Artery Disease
50%
Creatinine
50%
D Dimer
50%
Disease
10%
End Stage Renal Disease
10%
Fatty Acid Binding Protein
50%
Heart Failure
43%
Heart Failure with Preserved Ejection Fraction
100%
Heart Failure with Reduced Ejection Fraction
50%
Heart Left Ventricle Failure
25%
Kidney Disease
10%
Low Density Lipoprotein Cholesterol
50%
Myosin Binding Protein C
50%
Pitavastatin
50%
Population Study
13%
Rivaroxaban
50%
Statin (Protein)
50%
Vascular Disease
6%
Medicine and Dentistry
Acute Coronary Syndrome
10%
Acute Decompensated Heart Failure
68%
Acute Kidney Injury
100%
Adverse Outcome
50%
Amino Terminal Sequence
50%
Brain Natriuretic Peptide
50%
Cardiovascular System
50%
Cause of Death
18%
Chronic Kidney Disease
10%
Creatinine
56%
D-Dimer
50%
Disease
10%
Ejection Fraction
33%
End Stage Renal Disease
10%
Heart Failure
27%
Heart Failure with Preserved Ejection Fraction
100%
Heart Failure with Reduced Ejection Fraction
50%
Heart Left Ventricle Ejection Fraction
33%
Heart Left Ventricle Failure
8%
Intensive Care Unit
50%
Kidney Transplantation
10%
Logistic Regression Analysis
6%
Nephropathy
10%
Percutaneous Coronary Intervention
50%
Population Research
6%
Proportional Hazards Model
18%
Protein Z
50%
Proteinuria
50%
Renal Replacement Therapy
10%
Risk Stratification
18%
Two Dimensional Speckle Tracking Echocardiography
8%
Urinary System
50%
Keyphrases
12-month Mortality
5%
Acute Coronary Syndrome
10%
Acute Decompensated Heart Failure
10%
Acute Kidney Injury
50%
Adverse Outcomes
50%
All-cause Mortality
10%
Atherosclerotic Vascular Disease
6%
Cardiac Intensive Care Unit
100%
Creatinine
40%
Dialysis Treatment
10%
Emergency Procedures
6%
End-stage Kidney Disease
10%
Endpoint Determination
10%
Fatty
50%
Heterogeneous Patients
10%
High-dose Statin Therapy
5%
Hospital Admission
10%
Kaplan-Meier
10%
Kidney Disease Improving Global Outcomes
10%
Kidney Transplantation
10%
Liver Type
50%
Long-run Risk
10%
Long-term Prognostic Value
50%
Low-density Cholesterol
5%
Maintenance Dialysis
10%
Multivariate Cox Regression Analysis
10%
Myosin-binding Protein C
50%
Non-surgical
10%
Prognostic Value
10%
Protein Level
30%
Reclassification
10%
Reduced LVEF
16%
Risk Factors
10%
Risk Stratification
10%
Serum Creatinine
10%
Stable Cardiovascular Disease
50%
Stage 5 Chronic Kidney Disease
10%
Urinary Liver-type Fatty Acid Binding Protein
50%
